Gassert Chad's Insider Trades & SAST Disclosures
Gassert Chad's most recent trade in ANI Pharmaceuticals Inc was a trade of 14,362 Common Stock done . Disclosure was reported to the exchange on Feb. 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Gassert Chad.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 14,362 | 64,041 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 9,574 | 73,615 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 63.44 per share. | 01 Jul 2024 | 20,000 | 193,226 (1%) | 0% | 63.4 | 1,268,800 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 64.41 per share. | 03 Jun 2024 | 20,000 | 213,226 (1%) | 0% | 64.4 | 1,288,200 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 66.62 per share. | 01 May 2024 | 20,000 | 233,226 (1%) | 0% | 66.6 | 1,332,400 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 67.25 per share. | 01 Apr 2024 | 20,000 | 253,226 (2%) | 0% | 67.3 | 1,345,000 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 65.81 per share. | 11 Mar 2024 | 20,000 | 273,226 (2%) | 0% | 65.8 | 1,316,200 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.67 per share. | 29 Feb 2024 | 1,635 | 49,679 (0%) | 0% | 67.7 | 110,640 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 13,421 | 42,368 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 8,946 | 51,314 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 51.06 per share. | 01 Aug 2023 | 20,000 | 333,226 (2%) | 0% | 51.1 | 1,021,200 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Sale of securities on an exchange or to another person at price $ 53.43 per share. | 03 Jul 2023 | 20,000 | 353,226 (2%) | 0% | 53.4 | 1,068,600 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 17,369 | 17,369 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 11,578 | 28,947 (0%) | 0% | 0 | Common Stock | |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Purchase of securities on an exchange or from another person at price $ 27.87 per share. | 18 Mar 2022 | 5,000 | 393,226 (3%) | 0% | 27.9 | 139,343 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Purchase of securities on an exchange or from another person at price $ 27.15 per share. | 18 Mar 2022 | 5,000 | 388,226 (3%) | 0% | 27.1 | 135,744 | Common Stock |
| ANI Pharmaceuticals Inc | Chad Gassert | SVP - CORP. DEV. & STRATEGY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 383,226 | 383,226 (3%) | 3% | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges